Evidence map›Paper›PMID 39339509›Full record

ArticleMolecules (Basel, Switzerland)2024

A New Process for the Synthesis of Budesonide 21-Phosphate and Evaluation in a Murine Model of Inflammation.

Angela Corvino, Elisabetta Granato, Antonia Scognamiglio, Ferdinando Fiorino, Francesco Frecentese, Elisa Magli, Elisa Perissutti, Vincenzo Santagada, Giuseppe Cirino, Ida Cerqua and 7 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Angela CorvinoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.ORCID 0000-0002-0617-156X
Elisabetta GranatoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.ORCID 0000-0002-7207-5832
Antonia ScognamiglioDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.ORCID 0000-0002-4282-2788
Ferdinando FiorinoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.ORCID 0000-0001-7357-5751
Francesco FrecenteseDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.ORCID 0000-0001-8821-2937
Elisa MagliDepartment of Public Health, School of Medicine, University of Naples Federico II, Via Pansini, 5, 80131 Napoli, Italy.
Elisa PerissuttiDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.ORCID 0000-0002-1754-1191
Vincenzo SantagadaDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.
Giuseppe CirinoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.
Ida CerquaDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.ORCID 0000-0002-4363-7728
Rocco PaveseGenetic S.p.A., Via della Monica, n. 26, 84083 Castel San Giorgio, Italy.
Antonio PettiGenetic S.p.A., Via della Monica, n. 26, 84083 Castel San Giorgio, Italy.
Francesca PaveseGenetic S.p.A., Via della Monica, n. 26, 84083 Castel San Giorgio, Italy.
Francesco PettiGenetic S.p.A., Via della Monica, n. 26, 84083 Castel San Giorgio, Italy.
Fiorentina RoviezzoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.
Beatrice SeverinoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.ORCID 0000-0002-3887-8869
Giuseppe CaliendoDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.

Funding

Genetic Spa 0000
6 · The paper itself

Abstract

In this study, a new and straightforward process for the preparation of budesonide 21-phosphate (Bud-21P) and its disodium salt (Bud-21P-Na2) is described. The method results in a yield comparable to those obtained by diphosphoryl chloride, but it is more manageable, less expensive, and safer. The new compounds are characterized by better water solubility compared to the parent compound. Moreover, they have been evaluated for their anti-inflammatory activity and the obtained results clearly evidence that Bud-21P and Bud-21P-Na2 retained anti-inflammatory activity like the parent compound budesonide (Bud) in mice with cutaneous induced edema.

Indexed as

Anti-Inflammatory AgentsBudesonideDisease Models, AnimalInflammationAnimalsEdemaMiceSolubilityAnti-Inflammatory AgentsBudesonideanti-inflammatory drugsinflammationinhaled corticosteroidsphosphorylation

Identifiers

PMID39339509
PMCPMC11434587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.